title: IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
abstract: Anaplasma marginale is an important vector-borne rickettsia of ruminants in tropical and subtropical regions of the world. Immunization with purified outer membranes of this organism induces protection against acute anaplasmosis. Previous studies, with proteomic and genomic approach identified 21 proteins within the outer membrane immunogen in addition to previously characterized major surface protein1a-5 (MSP1a-5). Among the newly described proteins were VirB9, VirB10, and elongation factor-Tu (EF-Tu). VirB9, VirB10 are considered part of the type IV secretion system (TFSS), which mediates secretion or cell-to-cell transfer of macromolecules, proteins, or DNA-protein complexes in Gram-negative bacteria. EF-Tu can be located in the bacterial surface, mediating bacterial attachment to host cells, or in the bacterial cytoplasm for protein synthesis. However, the roles of VirB9, VirB10, and TFSS in A. marginale have not been defined. VirB9, VirB10, and EF-Tu have not been explored as vaccine antigens. In this study, we demonstrate that sera of cattle infected with A. marginale, with homologous or heterologous isolates recognize recombinant VirB9, VirB10, and EF-Tu. IgG2 from naturally infected cattle also reacts with these proteins. Recognition of epitopes by total IgG and by IgG2 from infected cattle with A. marginale support the inclusion of these proteins in recombinant vaccines against this rickettsia.
authors.affiliation: Embrapa Gado de Corte, Campo Grande, MS, Brasil. flabio@cnpgc.embrapa.br
authors.forename: Flábio R
authors.initials: FR
authors.lastname: Araújo
authors.forename: Cátia M
authors.initials: CM
authors.lastname: Costa
authors.forename: Carlos A N
authors.initials: CA
authors.lastname: Ramos
authors.forename: Thais A
authors.initials: TA
authors.lastname: Farias
authors.forename: Ingrid Ieda F de
authors.initials: II
authors.lastname: Souza
authors.forename: Elaine S P
authors.initials: ES
authors.lastname: Melo
authors.forename: Carina
authors.initials: C
authors.lastname: Elisei
authors.forename: Gracia M S
authors.initials: GM
authors.lastname: Rosinha
authors.forename: Cleber O
authors.initials: CO
authors.lastname: Soares
authors.forename: Stênio P
authors.initials: SP
authors.lastname: Fragoso
authors.forename: Adivaldo H
authors.initials: AH
authors.lastname: Fonseca
mesh_terms: D042322:Anaplasma marginale / Q000235:genetics / Q000276:immunology*; D000712:Anaplasmosis / Q000276:immunology / Q000517:prevention & control*; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D004797:Enzyme-Linked Immunosorbent Assay; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology*; D010444:Peptide Elongation Factor Tu / Q000008:administration & dosage / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D007074:Immunoglobulin G; D014614:Vaccines, Synthetic; D010444:Peptide Elongation Factor Tu